ADL
ALXN

Asset Dedication LLC’s Alexion Pharmaceuticals ALXN Stock Holding History

Asset Dedication LLC’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed – – 802
2018
Q2 		$0 Buy
+1
New +$117 ﹤0.01% 784
2016
Q4 		– Sell
-29
Closed -$4K – 433
2016
Q3 		$4K Sell
29
-30
-51% -$3.86K ﹤0.01% 364
2016
Q2 		$7K Hold
59
– – ﹤0.01% 302
2016
Q1 		$8K Hold
59
– – 0.01% 323
2015
Q4 		$11K Buy
+59
New +$10.3K 0.01% 396

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Asset Dedication LLC's ALXN Position: Q3 2018 in Review

Asset Dedication LLC sold out of Alexion Pharmaceuticals (ALXN) in Q3 2018, closing a stake of 1 share.

Asset Dedication LLC first reported a position in ALXN in Q4 2015 and held it in 5 quarters. The position peaked at $11K in Q4 2015. 584 funds tracked by Wall St. Rank hold ALXN as of Q3 2018.

  • Asset Dedication LLC reported no remaining Alexion Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Asset Dedication LLC sold 1 Alexion Pharmaceuticals share in Q3 2018.
  • Asset Dedication LLC first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 5 quarters.
  • Asset Dedication LLC's Alexion Pharmaceuticals position peaked at $11K in Q4 2015.
  • 584 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2018.

Based on Asset Dedication LLC's 13F filing for Q3 2018, filed 26 Oct 2018.